News
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...
Globus Medical Inc. stock grades by Barron's. View GMED fundamental and sentiment analysis powered by MarketGrader.
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
4d
Investor's Business Daily on MSNGlobus Medical Sees Relative Strength Rating Improve To 73Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
StockStory.org on MSN4d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results